Книги з теми "Papillomavirus humain (HPV)"

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Papillomavirus humain (HPV).

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 книг для дослідження на тему "Papillomavirus humain (HPV)".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Nardo, Don. Human papillomavirus (HPV). Detroit: Lucent Books, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Dizon, Don S. Questions & answers about human papilloma virus (HPV). Sudbury, Mass: Jones and Bartlett Publishers, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

United States. Indian Health Service. Genital human papillomavirus (HPV). Atlanta, Ga.]: Dept. of Health and Human Services, Centers for Disease Control and Prevention, Indian Health Service, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Syrjänen, Kari J. Human papillomavirus (HPV) involvement in esophageal carcinogenesis. New York: Nova Biomedical Books, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Dizon, Don S. Questions & answers about human papilloma virus (HPV). Sudbury, Mass: Jones and Bartlett Publishers, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Miller, Daniel L., and M. Sharon Stack, eds. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-21100-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Syrjänen, Kari J. Human papillomavirus (HPV) involvement in esophageal carcinogensis. Hauppauge, N.Y: Nova Science, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Zavaleta, Leticia Rocha. Immune response to human papillomavirus (HPV) in cervical cancer and cervical intraepithelial neoplasia. Manchester: University of Manchester, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Kwaśniewska, Anna. Infekcje wirusem brodawczaka ludzkiego (HPV-Human Papillomavirus): Surowiczy poziom antyoksydantow oraz rola zywienia w dysplazji szyjki macicy. Poznań: Wydawnictwo Naukowe Uniwersytet im. Adama Mickiewicza w Poznaniu, 1998.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Thomas, David Peter. Studies on tumourigenesis in transgenic mice expressing the early region genes of human papillomavirus type 16 (HPV-16). Birmingham: University of Birmingham, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
11

Doorbar, John. Identification of proteins encoded by the major open reading frames of human papillomavirus type 1 (HPV-1): Productionof specific antisera. Birmingham: University of Birmingham, 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
12

United States. Congress. House. A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of screening tests for human papillomavirus (HPV). Washington, D.C: U.S. G.P.O., 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
13

Villafana, Alejandrina Canelo. Vaccinating Children for the Human Papillomavirus (HPV): Predictors of Parents Vaccinating Their Child and Providers Recommending a New Linguistically and Culturally Tailored Video Intervention Designed to Increase Vaccination Initiation and Completion. [New York, N.Y.?]: [publisher not identified], 2019.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
14

L, Sutton Amy, ed. Sexually transmitted diseases sourcebook: Basic consumer health information about chlamydial infections, gonorrhea, hepatitis, herpes, hiv/aids, human papillomavirus, pubic lice, scabies, syphilis, trichomoniasis, vaginal infections, and other sexually transmitted diseases ... 3rd ed. Detroit, MI: Omnigraphics, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
15

Inc, Omnigraphics. Sexual health information for teens: Health tips about sexual development, reproduction, contraception, and sexually transmitted infections including facts about puberty, sexuality, birth control, HIV/AIDS, human papillomavirus, chlamydia, gonorrhea, herpes, and more. Detroit, MI: Omnigraphics, Inc., 2016.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
16

Magill, Elizabeth. Sexual health information for teens: Health tips about sexual development, reproduction, contraception, and sexually transmitted infections : including facts about puberty, sexuality, birth control, hiv/aids, human papillomavirus, chlamydia, gonorrhea, herpes, and more. 3rd ed. Detroit, Mich: Omnigraphics, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
17

Sutton, Amy L. Sexually transmitted diseases sourcebook: Basic consumer health information about sexual health and the screening, diagnosis, treatment, and prevention of common sexually transmitted diseases (STDs), including chancroid, chlamydia, gonorrhea, herpes, hepatitis, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), human papillomavirus (HPV), syphilis, and trichomoniasis ; along with facts about risk factors and complications, trends and disparities in infection rates, tips for discussing STDs with sexual partners, a glossary of related terms, and resources for additional help and information. 5th ed. Detroit, MI: Omnigraphics, Inc., 2013.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
18

Laura, Larsen, ed. Sexually transmitted diseases sourcebook: Basic consumer health information about the symptoms and treatment of chlamydia, gonorrhea, hepatitis, herpes, HIV/Aids, human papillomavirus (HPV), pelvic inflammatory disease, syphilis, trichomoniasis, vaginal infections, and other sexually transmitted diseases (STDs), including recent facts about prevalence, risk factors, diagnosis, treatment, and prevention; along with tips on discussing and living with STDs, updates on current research and vaccines, a glossary of related terms, and resources for additional help and information. 4th ed. Detroit, MI: Omnigraphics, Inc., 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
19

GOVERNMENT, US. An Act to Amend Title XIX of the Social Security Act to Provide Medical Assistance for Certain Women Screened and Found to Have Breast or Cervical Cancer under a Federally Funded Screening Program to Amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with Respect to Surveillance and Information Concerning the Relationship between Cervical Cancer and the Human Papillomavirus (HPV), and for Other Purposes. [Washington, D.C: U.S. G.P.O., 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
20

Dizon, Don S., and Michael L. Krychman. Questions and Answers about Human Papilloma Virus(HPV). Jones & Bartlett Learning, LLC, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
21

Negari, Shelly Ben-Harush, and Jessica A. Kahn. Human Papillomavirus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0009.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Human papillomavirus (HPV) is a ubiquitous, single-stranded DNA virus that is commonly sexually transmitted and an important cause of cervical cancer. Manifestations of infection in the perinatal and childhood periods are recurrent respiratory papillomatosis (RRP) and anogenital warts (AGWs). Children with respiratory papillomatosis most commonly develop papillomas in the larynx, but papillomas may develop in any location along the respiratory tract. Although RRP is rare, it is the most common benign neoplasm of the larynx among children and the second-most-frequent cause of childhood hoarseness. AGWs are uncommon in the perinatal period and typically benign. They may develop on the vulva, hymen, vagina, urethra, or perianal area in girls and on the perianal area in boys. The clinical manifestations, epidemiology, diagnostic studies, and management strategies pertinent to these infections are reviewed.
22

Nardo, Don. Human Papillomavirus (HPV) (Diseases and Disorders). Lucent Books, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
23

Miller, Daniel L., and M. Sharon Stack. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Springer International Publishing AG, 2015.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
24

Miller, Daniel L., and M. Sharon Stack. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Springer, 2015.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
25

Bulterys, Marc, Julia Brotherton, and Ding-Shinn Chen. Prevention of Infection-Related Cancers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0066.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
This chapter discusses primary prevention measures that disrupt transmission of oncogenic infections. It begins by discussing vaccination against hepatitis B virus (HBV) and human papillomavirus (HPV), two major causes of cancer for which safe and effective vaccines are currently available. It briefly discusses the importance of treatment and prophylaxis against human immunodeficiency virus type 1 (HIV-1), which potentiates the virulence of other viral infections as well as directly increasing the incidence of non-Hodgkin lymphoma. It does not discuss the treatment of HBV or hepatitis C virus (HCV) infection, since these are considered in Chapters 25 and 33. Also beyond the scope of this chapter are the randomized clinical trials currently underway to assess the efficacy and feasibility of eradication of Helicobacter pylori (Chapters 24, 31), vaccination against Epstein-Barr virus (EBV) (Chapters 24, 26, 39), or the prevention of schistosomiasis and liver flukes (Chapters 24, 33, and 52).
26

Vanderpool, Robin C., Heather M. Brandt, and Meagan R. Pilar. Implementation Strategies for Increasing Rates of Human Papillomavirus Vaccination. Edited by David A. Chambers, Wynne E. Norton, and Cynthia A. Vinson. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190647421.003.0009.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
This case study describes the unique issues associated with human papillomavirus (HPV) vaccination, including its role in cancer prevention, suboptimal initiation and completion rates among adolescents nationwide, and barriers to population-level uptake of the vaccine. It also provides an overview of evidence-based implementation strategies that have been used broadly within the HPV vaccination context and within specific projects that have capitalized on community partnerships, clinical systems changes, alternative settings, and multipronged approaches to improve vaccine outcomes. In addition, it outlines an agenda for improving HPV vaccination outcomes across the population and among disparate communities through the lens of implementation science, including the use of multilevel interventions focused on varying levels of influence ranging from intrapersonal to policy.
27

Prendiville, Walter. Health Professional's HPV Handbook: Human Papillomavirus and Cervical Cancer. Taylor & Francis Group, 2017.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
28

Burchell, Ann, and Eduardo Franco1. The impact of immunization on cancer control: the example of HPV vaccination. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199550173.003.0006.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Chapter 6 reviews briefly the role of infections as causal agents in cancer, describes anti-hepatitis B virus (HBV) immunization as the first cancer vaccine paradigm, and finally focuses on the latest paradigm of prophylactic vaccination against human papillomavirus (HPV) infection as the new front in cancer prevention.
29

Franceschi, Silvia, Hashem B. El-Serag, David Forman, Robert Newton, and Martyn Plummer. Infectious Agents. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0024.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Eleven infectious agents (seven viruses, three parasites, and one bacterium) have been classified by the International Agency for Research on Cancer as carcinogenic to humans for one or more cancer sites: hepatitis B virus; hepatitis C virus; thirteen types of human papillomavirus (HPV); human immunodeficiency virus type 1 (HIV-1); human T-cell leukemia virus type 1; Epstein-Barr virus; Kaposi sarcoma herpesvirus; Helicobacter pylori; Opisthorchis viverrini; Clonorchis sinensis; and Schistosoma haematobium. Other infectious agents, such as Merkel cell polyomavirus, Plasmodium falciparum, and cutaneous HPVs, have been classified as “probably carcinogenic” or “possibly carcinogenic.” Accurate biomarkers of chronic infection have been essential for estimating risk and ascribing a causal role to infectious agents in cancer. Of the 14 million cases of cancer estimated to have occurred worldwide in 2012, 2.2 million were caused by infectious agents. Vaccination and screen-and-treat programs have the potential for greatly reducing the burden of cancer caused by infections.
30

Human Papillomavirus and Related Diseases - From Bench to Bedside - Research aspects. InTech, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
31

The Health Professional's HPV Handbook: Volume 1: Human Papillomavirus and Cervical Cancer. Informa Healthcare, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
32

Herrero, Rolando, and Raul Murillo. Cervical Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0048.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Cervical cancer is the fourth most common cancer in women worldwide, with more than 500,000 cases and 250,000 deaths per year. The disease is characterized by marked regional differences, with more than 80% of the cases and deaths occurring in developing countries. The etiology and natural history of the disease are very well studied, with persistent infection with one of thirteen human papillomavirus (HPV) types now considered to be a necessary cause. The molecular mechanisms have also been elucidated and are mediated mainly by the expression of viral oncogenes that interfere with cellular pathways. The two most common HPV types, namely HPV-16 and HPV-18, are associated with about 70% of all cases around the world. Immunologic (e.g., HIV infection), hormonal (e.g., high parity), environmental (e.g., smoking), and genetic (e.g., HLA type) cofactors determine the risk of persistence and cancer among women harboring HPV infection.
33

Kahan, Dan M., and Ashley R. Landrum. A Tale of Two Vaccines—and Their Science Communication Environments. Edited by Kathleen Hall Jamieson, Dan M. Kahan, and Dietram A. Scheufele. Oxford University Press, 2017. http://dx.doi.org/10.1093/oxfordhb/9780190497620.013.18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
This chapter examines the difference in the US public’s reactions to proposals for universal administration of two adolescent immunizations: the human papillomavirus (HPV) vaccine, which provoked a firestorm of political controversy, and the Hepatitis B (HBV) vaccine, which aroused no such opposition. This chapter argues that the reason for this was that the public became familiar with the latter (but not the former) in a polluted science communication environment. It identifies decisions made by the vaccine’s manufacturer that drove the HPV vaccine off the nonpoliticized administrative-approval path followed by the HBV vaccine and every other mandated childhood vaccine and onto a highly politicized, highly partisan legislative one that predictably provoked identity-protective cognition. The chapter argues that such controversy will likely recur unless protection of the science communication environment is itself made a self-conscious object of the institutions, governmental and nongovernmental, that play a role in the dissemination of decision-relevant science.
34

Vermund, Sten Halvor. Association of human immunodeficency virus and genital human papillomavirus with pathologic cervical cytology. 1990.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
35

Djajadiningrat, Rosa, and Simon Horenblas. Penile cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0093.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Penile cancer is a rare malignancy in the Western world, but in Asia, Africa, and South Africa the incidence is much higher. Risk factors, including phimosis, human papillomavirus (HPV), smoking, chronic inflammatory conditions, psoralen ultraviolet photochemotherapy, genital warts, and HIV infection play a role in the pathogenesis of penile cancer. Approximately 95% of all penile tumours are squamous cell carcinomas (PSCC) and the large majority arise from the prepuce or glans. PSCC has a strong tendency for lymphatic dissemination, but cure can still be attained in patients with inguinal involvement. The most commonly used staging system is the 2009 TNM classification for penile cancer. Surgical resection has been the mainstay of treatment in penile carcinoma, including penile-preserving techniques, partial and total penectomy. The aim of surgery is minimizing loss of anatomy and function, without jeopardizing oncological results.
36

Grulich, Andrew E., Fengyi Jin, and I. Mary Poynten. Anal Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0037.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Anal canal cancer is a generally uncommon cancer that has been increasing in incidence for several decades. In most geographic locations, squamous cell carcinoma (SCC) accounts for 70% or more of cases, and incidence is slightly higher in women than in men. The remaining cases are mainly adenocarcinoma, but the degree to which this represents misclassified rectal cancer is uncertain. In almost all cases, anal SCC is caused by persistent infection with high-risk types of human papillomavirus (HPV); HPV-16 accounts for 75% or more of all cases. Survival is highly stage-dependent, and cure is usual if the cancer is diagnosed early. The main risk factor is anal exposure to HPV, and for this reason homosexual men are at particularly high risk. In women, risk is increased in those with higher numbers of sexual partners, and in those with a history of HPV-related disease at genital sites.
37

Madeleine, Margaret M., and Lisa G. Johnson. Vulvar and Vaginal Cancers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0049.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Vulvar and vaginal cancers are rare and predominantly involve squamous cell carcinomas. Some studies combine these cancers, presumably because of their rarity, anatomic proximity, and shared risk factors. Major risk factors include human papillomavirus (HPV) and cigarette smoking. This chapter explores the similarities and important differences in etiology between these cancer sites. In addition to its focus on invasive cancer, the chapter also discusses high-grade precursor lesions, or in situ disease, that sometimes progress to cancer and must, therefore, be treated.
38

Monsonego, J. Papillomaviruses in Human Pathology: Recent Progress in Epidermoid Precancers (Serono Symposia Publications from Raven Press). Lippincott Williams & Wilkins, 1990.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
39

Hashibe, Mia, Erich M. Sturgis, Jacques Ferlay, and Deborah M. Winn. Oral Cavity, Oropharynx, Lip, and Salivary Glands. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0029.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Cancers of the oral cavity, oropharynx, lip, and salivary glands are malignancies of the head and neck. Some of these cancer sites share risk factors, although each has distinctive anatomic, epidemiologic, and clinical features. Oral cavity cancers arise on the inner lip and buccal mucosa, anterior two-thirds of the tongue, gum, hard palate, and floor of mouth. These cancers are strongly associated with the use of smoked and smokeless tobacco products, heavy alcohol consumption, and chewing of betel quid or pan, but only minimally associated with prior infection with human papillomavirus (HPV). In contrast, oropharyngeal cancers affect the posterior one-third (base) of the tongue, tonsils, soft palate, and other oropharyngeal tissues and are strongly associated with HPV-16 infection as well as with the use of tobacco, alcohol, and betel quid. In principle, tumors of the oral cavity, oropharynx, and lip are among the most preventable forms of cancer.
40

Maza, Mauricio, Karla Alfaro, Julia C. Gage, and Miriam Cremer. Adopting the PREVENTABLE Model. Edited by David A. Chambers, Wynne E. Norton, and Cynthia A. Vinson. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190647421.003.0030.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The Cervical Cancer Prevention in El Salvador (CAPE) program completed a series of human papillomavirus (HPV)-based screening demonstration projects that resulted in modification of screening guidelines and set the stage for national implementation of HPV primary screening. This chapter outlines the elements that contributed to the success of CAPE within a process of change model called PREVENTABLE. The model rests on two pillars, political will and evidence, which feed and complement one another. Recognizing political windows of opportunity and obtaining government commitment are crucial to support innovative programs and effect significant transformations. Simultaneously, convincing evidence motivates and channels political will. Thus, primary drivers of the model are research and evaluation of outcomes that reinforce the main pillars; secondary drivers are context dependent, including education, advocacy, negotiation, the legal framework, and budgetary constraints. The experiences from CAPE and PREVENTABLE provide possible blueprints to renovate existing paradigms of cancer control programs.
41

Vigil, Karen J. Sexually Transmitted Diseases. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0044.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Sexually transmitted diseases (STDs) are common in HIV-infected patients. Education and counseling on changes in sexual behaviors of patients with STDs and their sexual partners, identification of asymptomatic infection, and effective diagnosis and treatment are the cornerstone for prevention. HIV-infected patients with syphilis should have a detailed neurologic examination. Penicillin is the treatment of choice for syphilis. Gonococcal infection is an important cause of urethritis, cervicitis, pharyngitis, and proctitis in HIV-infected sexually active patients. Dual therapy for gonorrhea and chlamydia is recommended. Most Chlamydia trachomatis infections are asymptomatic and thus detected only by routine, periodic screening. Human papillomavirus is the most common STD in the United States.
42

Török, M. Estée, Fiona J. Cooke, and Ed Moran. Sexually transmitted infections. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199671328.003.0018.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
This chapter covers the diagnosis and management of sexually transmitted infections, including bacterial vaginosis, with causes including vaginal discharge, vulvovaginal candidiasis, and trichomoniasis. The chapter also covers vulvovaginal candidiasis, genital warts or anogenital warts caused by human papillomavirus, tropical genital ulceration (which is commoner in patients presenting with sexually transmitted infections in the developing world and is an important factor in the spread of HIV), genital herpes, pelvic inflammatory disease, toxic shock syndrome, gonorrhoea, chlamydia, trichomoniasis, and syphilis.
43

Gottlieb, Samantha D. Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. Rutgers University Press, 2018.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
44

Gottlieb, Samantha D. Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. Rutgers University Press, 2018.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
45

Gottlieb, Samantha D. Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. Rutgers University Press, 2017.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
46

News, PM Medical Health. 21st Century Complete Medical Guide to the Cervical Cancer Vaccine, Gardasil, Human Papillomavirus (HPV), Related STDs, Authoritative CDC, NIH, and FDA Documents, Clinical References. Progressive Management, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
47

Schrag, Brian, and Kathleen J. Van Buren. Improve Results. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190878276.003.0007.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Step 6 helps readers to follow guidelines for determining whether artistic products are effective; design an evaluative process using a conceptual approach; and design a recurring cycle of evaluation. It begins with a case study demonstrating how the Global Alliance to Immunize Against AIDS Vaccine Foundation (GAIA VF) has integrated research and evaluation in their program promoting storytelling cloths to educate communities in Mali about human papillomavirus (HPV) vaccination. While pointing out the complexity of assessment processes, this section then offers these broad suggestions: trust local systems for evaluation; consider the effects of new artistry; continue researching local arts to gain deeper understandings of local perspectives; and think about when to evaluate programs. This section also offers practical suggestions for how to evaluate programs and whom to include in evaluation processes. Finally, it features a discussion of how projects can fail and what we can learn from failure.
48

Frisch, Morten. Penile Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0055.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Penile cancers are rare primary malignancies located on the glans, foreskin, or shaft of the penis, excluding the urethra. The vast majority of penile cancers are epithelial tumors representing histological subtypes of squamous cell carcinoma (SCC). Most penile SCCs are believed to develop through pre-invasive lesions known as penile intraepithelial neoplasia and penile carcinoma in situ. They account for 0.1%–0.3% of all incident cancers (excluding non-melanoma skin cancers) in the United States and other developed countries and up to 1% of all cancers in some countries in sub-Saharan Africa. Penile cancers are rare in men younger than 40 years, and are typically diagnosed among men above age 60. The two most important risk factors are pathological phimosis and infection with high-risk types of human papillomaviruses (HPV), both of which are preventable conditions.
49

Charles, Nicole. Suspicion. Duke University Press, 2021. http://dx.doi.org/10.1215/9781478022251.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
In 2014 Barbados introduced a vaccine to prevent certain strains of the human papillomavirus (HPV) and reduce the risk of cervical cancer in young women. Despite the disproportionate burden of cervical cancer in the Caribbean, many Afro-Barbadians chose not to immunize their daughters. In Suspicion, Nicole Charles reframes Afro-Barbadian vaccine refusal from a question of hesitancy to one of suspicion. Drawing on ethnographic fieldwork, black feminist theory, transnational feminist studies and science and technology studies, Charles foregrounds Afro-Barbadians' gut feelings and emotions and the lingering trauma of colonial and biopolitical violence. She shows that suspicion, far from being irrational, is a fraught and generative affective orientation grounded in concrete histories of mistrust of government and coercive medical practices foisted on colonized peoples. By contextualizing suspicion within these longer cultural and political histories, Charles troubles traditional narratives of vaccine hesitancy while offering new entry points into discussions on racialized biopolitics, neocolonialism, care, affect, and biomedicine across the Black diaspora. Duke University Press Scholars of Color First Book Award recipient
50

Sexually transmitted diseases sourcebook: Basic consumer health information about chlamydial infections, gonorrhea, hepatitis, herpes, hiv/aids, human papillomavirus, pubic lice, scabies, syphilis, trichomoniasis, vaginal infections, and other sexually transmitted diseases ... 3rd ed. Detroit, MI: Omnigraphics, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

До бібліографії